2088. Deputy Louis O'Hara asked the Minister for Health the steps being taken to ensure that the HSE recognises and responds to the time-critical nature of Friedreich's ataxia during the current price negotiations for Skyclarys; the way in which the commitments outlined in the National Rare Disease Strategy 2025-2030, and the 2026 IPHA Framework Agreement which aims for a 180-day decision timeline are being applied i…
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
27,342 questions match, newest first.
2089. Deputy Pádraig Rice asked the Minister for Health if she will use the opportunity of the forthcoming United Nations Commission on Population and Development (CPD) fifty-ninth session on 13 to 17 April 2026 to showcase Ireland's positive experience of reforming law and policy and expanding access to reproductive health and rights, including at events and discussions sponsored by Member States and international o…
2090. Deputy Ryan O'Meara asked the Minister for Health the alternative options that are available to parents with children awaiting urgent dental care procedures, who are currently on long public patient waiting lists and can not afford private care; and if she will make a statement on the matter. [20245/26]
2091. Deputy Michael Fitzmaurice asked the Minister for Health the steps being taken to ensure that the HSE recognises and responds to the time-critical nature of Friedreich's ataxia during the current price negotiations for Skyclarys; and if she will make a statement on the matter. [20251/26]
2092. Deputy Michael Fitzmaurice asked the Minister for Health the way in which the commitments outlined in the National Rare Disease Strategy 2025-2030, and the 2026 IPHA Framework Agreement, which aims for a 180-day decision timeline, being applied in this case to prevent further delays in addressing this clear unmet need; and if she will make a statement on the matter. [20252/26]
2093. Deputy Ken O'Flynn asked the Minister for Health whether her Department has approved or mandated the establishment of a national dataset for the purposes of planning, governance, oversight and evaluation of gender identity healthcare services provided to children and adolescents within the public health system; if not, whether such a dataset will be introduced; and the timeframe for its implementation. [20261/2…
2094. Deputy Ken O'Flynn asked the Minister for Health whether her Department receives any aggregated national data from the Health Service Executive regarding the number of children and adolescents referred to gender identity services each year; if so, the annual totals for each of the years 2018 to 2025; and if she will make a statement on the matter. [20262/26]
2095. Deputy Ken O'Flynn asked the Minister for Health whether any national clinical audit, patient safety review or governance evaluation has been undertaken since 2020 in respect of gender identity services provided to children and adolescents within the public health system; if so, to provide the dates and scope of such reviews; and if she will make a statement on the matter. [20263/26]
2096. Deputy Ken O'Flynn asked the Minister for Health whether the Department has received the report of the expert group established by the Health Service Executive to consider the implications of the final Cass Review for gender healthcare services in Ireland; if so, the date on which the report was received; and whether she intends to publish the report. [20264/26]
2097. Deputy Ken O'Flynn asked the Minister for Health the formal national clinical governance framework that currently applies to gender identity healthcare services provided to minors pending completion of the updated national model of care; and the specific safeguarding standards required under that framework. [20265/26]
2098. Deputy Ken O'Flynn asked the Minister for Health whether her Department has issued any policy direction, guidance or instruction to the Health Service Executive following publication of the final Cass Review regarding the provision of gender identity healthcare services to children and adolescents in Ireland. [20266/26]
2099. Deputy Donna McGettigan asked the Minister for Health the number of students in unpaid work placements in both the health care and education sectors; the total value to these sectors of this work; and if she will make a statement on the matter. [20273/26]
2100. Deputy Ken O'Flynn asked the Minister for Health the formal methodological framework used by her Department when evaluating international clinical guidance prior to incorporation into national healthcare policy; and whether such a methodology was applied in respect of international guidance on gender identity healthcare between 2018 and 2023. [20274/26]
2101. Deputy Ken O'Flynn asked the Minister for Health the date on which the Health Service Executive completed its review of the Cass Review; whether the completed review has been submitted to her Department; the date on which her Department received the document, if applicable; whether she intends to publish the review; and if publication is not intended, the reason the document will not be placed in the public dom…
2102. Deputy Ken O'Flynn asked the Minister for Health the terms of reference issued for the Health Service Executive review of the Cass Review; the names or professional roles of the clinical experts who conducted that review; the governance structure under which the work was undertaken; and whether the review included consideration of safeguarding and clinical risk factors affecting children and adolescents. [20289…
2103. Deputy Ken O'Flynn asked the Minister for Health whether the Health Service Executive review of the Cass Review identified any recommendations relating to safeguarding, diagnostic standards, risk mitigation, or clinical governance in the treatment of children and adolescents presenting with gender incongruence or dysphoria; and whether such recommendations are being incorporated into the developing Model of Car…
2104. Deputy Ken O'Flynn asked the Minister for Health the expected timeline for the completion and publication of the updated Model of Care for gender healthcare services being developed by the Health Service Executive; the stages remaining in that process; and whether the Model of Care will be subject to public or professional consultation before adoption. [20291/26]
2105. Deputy Ken O'Flynn asked the Minister for Health whether the State currently maintains a national dataset recording referrals, diagnoses, treatment pathways, clinical interventions and outcomes for persons receiving gender healthcare services in Ireland; if no such dataset currently exists, when she expects one to be established; and whether the development of such a dataset forms part of the updated Model of C…
2106. Deputy Ken O'Flynn asked the Minister for Health whether the Department of Health or the Health Service Executive conducts periodic clinical audits or outcome evaluations of gender healthcare services delivered within the public health system; if such audits are conducted, the frequency and scope of those audits; and if not, whether such a mechanism will be introduced as part of the new Model of Care. [20293/26…
2107. Deputy Ken O'Flynn asked the Minister for Health the evidence base being relied upon by the Health Service Executive in developing the updated Model of Care for gender healthcare services; whether international clinical reviews, including the Cass Review and equivalent reviews in other jurisdictions, are being formally considered; and how such evidence will inform Irish clinical standards. [20294/26]
2108. Deputy Ken O'Flynn asked the Minister for Health the respective roles of her Department and the Health Service Executive in approving the updated Model of Care for gender healthcare services; whether the final Model of Care will require ministerial approval; and whether the Department retains oversight of safeguarding standards applicable to services for persons under 18. [20295/26]
2109. Deputy Ken O'Flynn asked the Minister for Health the total expenditure incurred by the Primary Care Reimbursement Service on salbutamol nebules dispensed under the General Medical Services Scheme in each month from January 2024 to date in 2026. [20299/26]
2110. Deputy Ken O'Flynn asked the Minister for Health the number of claims submitted for salbutamol nebules or equivalent short-acting bronchodilator nebules under the General Medical Services Scheme, the Drugs Payment Scheme, and the Long-Term Illness Scheme, in each of the years 2024 and 2025. [20300/26]
2111. Deputy Ken O'Flynn asked the Minister for Health the number of claims for salbutamol nebules rejected or unpaid by the Primary Care Reimbursement Service in 2024 and 2025, and the reasons for rejection. [20301/26]
2112. Deputy Ken O'Flynn asked the Minister for Health whether the Department or the HSE issued any clinical or reimbursement guidance to pharmacists relating to salbutamol nebule shortages during 2024 or 2025, and if so to provide the details. [20302/26]